Alterity Therapeutics Stock (NASDAQ: ATHE)
|Day Range0.45 - 0.48||52 Wk Range0.4 - 1.23||Open / Close0.46 / 0.48||Float / Outstanding- / 40.1M|
|Vol / Avg.63.9K / 111.6K||Mkt Cap19.1M||P/E-||50d Avg. Price0.58|
|Div / Yield-||Payout Ratio-||Total Float-||EPS-4.62|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Alterity Therapeutics (NASDAQ: ATHE) through any online brokerage.
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Ladenburg Thalmann on Wednesday, August 3, 2022. The analyst firm set a price target for 2.00 expecting ATHE to rise to within 12 months (a possible 319.20% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $0.4771 last updated September 29, 2022, 7:45 PM UTC.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q3 earnings are confirmed for Sunday, October 16, 2022.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.